Bemarituzumab Plus Mfolfox6 As First-Line Treatment in East Asian Patients with FGFR2b-overexpressing Locally Advanced or Metastatic Gastric/gastroesophageal Junction Cancer: Subgroup of FIGHT Final Analysis.
Gastric Cancer（2024）
Key words
Bemarituzumab,FGFR2b,Gastric cancer,mFOLFOX6,Targeted therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined